It was reported that on (b)(6) 2022, a patient presented with grade 4 secondary mitral regurgitation for a mitraclip procedure.Two xtw clips were implanted, one central and the other centro lateral.The mr was reduced to grade 1.On (b)(6) 2023, the patient returned symptomatic.The patient was symptomatic with dyspnea and recurrent grade 4 mr.A transesophageal echocardiogram (tee) was performed.It was noted that the centro lateral xtw was detached from the anterior leaflet.A single leaflet device attachment (slda) occurred.On (b)(6) 2023 a second clip intervention was performed.One additional clip was implanted and the mr was reduced from grade 4 to 1.There were no adverse patient sequelae.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Additionally, a review of the complaint history identified no similar complaints from the lot.All available information was investigated, and a cause for the reported slda associated with the clip detaching from the anterior leaflet cannot be determined.Mitral valve insufficiency/ regurgitation (mr) resulting in dyspnea appears to be due to the slda.Dyspnea and mitral regurgitation are known possible complications associated with mitraclip procedures.Unexpected medical intervention and hospitalization were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
|